PHASE IB/II CLINICAL TRIAL OF ALPELISIB AND TUCATINIB IN PATIENTS WITH PIK3CA-MUTANT HER2-POSITIVE METASTATIC BREAST CANCER
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
CTRC Inpatient
Department Specific Free Standing Clinic
LSU Health Sciences Center
Mt. Sinai Comprehensive Cancer Center
University of Colorado Hospital
USD Moores Cancer Center
UW Carbone Cancer Center
Principal Investigator
Elena Shagisultanova, MD, PhD
Study ID
Protocol Number: 21-5033
More information available at ClinicalTrials.gov: NCT05230810
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers